Skip to main content
SpringerLink
Log in

Paradoxical role of lipid metabolism in heart function and dysfunction

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The heart utilizes fatty acids as a substrate in preference to glucose for the production of energy. The rate of fatty acid uptake and oxidation by heart muscle is controlled by the availability of exogenous fatty acids, the rate of acyl translocation across the mitochondrial membrane and the rate of acetyl-CoA oxidation by the citric acid cycle. Carnitine acyl-CoA tranferase appears to have an important function in coupling the fatty acid activation and acyl transfer to the oxidative phosphorylation. Activated fatty acids are also utilized for the synthesis of triglycerides and membrane phospholipids in the myocardium. The inhibition of long chain acyl-carnitine transferase I reduces the oxidation of fatty acids and promotes the synthesis of lipids in the myocardium. Accumulation of fatty acids and their metabolites such as long chain acyl-CoA and long chain acyl-carnitine has been associated with cardiac dysfunction and cell damage in both ischemic and diabetic hearts. Alterations in the composition of membrane phospholipids are also considered to change the activities of various membrane bound enzymes and subsequently heart function under different pathophysiological conditions. Chronic diabetes was found to be associated with increased plasma lipids, subcellular defects and cardiac dysfunction. Lowering the plasma lipids or reducing the oxidation of fatty acids by agents such as etomoxir, an inhibitor of palmitoylcarnitine transferase I was found to promote glucose utilization and remodel the subcellular membranous organelles in the heart. The crucial role of fatty acids in membrane phospholipids for the maintenance of structural integrity and production of energy for cardiac contractile activity as well as the toxic effects of fatty acids and their long chain acyl-derivatives support the concept of `lipid paradox' in the myocardium. (Mol Cell Biochem116: 3–9, 1992)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bing RJ: Cardiac metabolism. Physiol Rev 45: 171–213, 1965

    Google Scholar 

  2. Neely JR, Rovetto MJ, Oram JF: Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Disease 15: 289–329, 1972

    Google Scholar 

  3. Neely JR, Morgan HE: Relationship between carbohydrate and lipid metabolism and the energy balance of the heart muscle. Ann Rev Physiol 36: 413–459, 1974

    Google Scholar 

  4. Opie LH: Effects of regional ischemia on metabolism of glucose and fatty acids. Relative rates of aerobic and anaerobic energy production during myocardial infarction and comparison with effects of anoxia. Circ Res 38 (Suppl 1): 152–186, 1976

    Google Scholar 

  5. Masoro EJ: Lipids and lipid metabolism. Ann Rev Physiol 39: 301–321, 1977

    Google Scholar 

  6. Opie LE: Role of carnitine in fatty acid metabolism of normal and ischemic myocardium. Am Heart J 97: 375–388, 1979

    Google Scholar 

  7. Randle PJ, Tubbs PK: Carbohydrate and fatty acid metabolism. In: RM Berne and N Sperelakis (eds.) The Cardiovascular System, Vol. I, The Heart. Am Physiol Soc, Bethesda, 1979, pp 805–844

    Google Scholar 

  8. Vary TC, Reibel DK, Neely JR: Control of energy metabolism of heart muscle. Ann Rev Physiol 43: 419–430, 1981

    Google Scholar 

  9. Liedtke JA: Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Disease 23: 321–336, 1981

    Google Scholar 

  10. Van der Vusse GJ, Stam H: Lipid and carbohydrate metabolism in the ischemic heart. Basic Res Cardiol 82 (Suppl I): 149–154, 1987

    Google Scholar 

  11. Oliver MF, Kurien VA, Greenwood TW: Relation between serum free fatty acids and arrhytbmias and death after acute myocardial infarction. Lancet 1: 710–715, 1968

    Google Scholar 

  12. Oliver MF: Metabolic response during impending myocardial infarction II. Clinical implications. Circulation 45: 491–500, 1972

    Google Scholar 

  13. Kjekshus JK, Mjos OD: Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart. J Clin Invest 51: 1767–1776, 1972

    Google Scholar 

  14. Opie LH, Tansey M, Kennelly BM: Proposed metabolic vicious circle in patients with large myocardial infarcts and high plasma free fatty acid concentrations. Lancet 2: 890–892, 1977

    Google Scholar 

  15. Neely JR, Bowman RH, Morgan HE: Effects of ventricular pressure development and palmitate on glucose transport. Am J Physiol 216: 804–811, 1969

    Google Scholar 

  16. Spitzer JJ: Application of tracers in studying free fatty acid metabolism of various organs in vivo. Fed Proc 34: 2242–2245, 1975

    Google Scholar 

  17. Stein O, Stein Y: Lipid synthesis, intracellular transport and storage III. Electron microscopic radioautographic study of the rat heart perfused with tritiated oleic acid. J Cell Biol 36: 63–77, 1968

    Google Scholar 

  18. Fritz IB, Kaplan E, Yue KTN: Specificity of carnitine action on fatty acid oxidation by heart muscle. Am J Physiol 202: 117–121, 1962

    Google Scholar 

  19. Adams RJ, Cheen DW, Gupta S, Johnson D, Wallic ET, Wang T, Schwartz A: In vitro effects of palmitoyl carnitine on cardiac plasma membrane Na+, K+-ATPase and sarcoplasmic reticulum Ca+-ATPase and Ca+-transport. J Biol Chem 254: 12404–12410, 1983

    Google Scholar 

  20. Dhalla NS, Kolar F, Shah KR, Ferrari R: Effects of some Lcarnitine derivatives on heart membrane ATPase. Cardiovasc Drugs 5: 25–30, 1991

    Google Scholar 

  21. Idell-Wenger JA, Grotoyohann LW, Neely JR: Coenzyme A and carnitine distribution in normal and ischemic hearts. J Biol Chem 253: 4310–4318, 1978

    Google Scholar 

  22. Feuvray D, Idell-Wenger JA, Neely JR: Effects of ischemia on rat myocardial function and metabolism in diabetes. Circ Res 44: 322–329, 1979

    Google Scholar 

  23. Shug AL, Thomsen JH, Folts JD, Bittar N, Klein MI, Koke JR, Huth PJ: Changes in tissue levels of carnitine and other metabolites during myocardial ischemia and anoxia. Arch Biochem Biophys 187: 25–33, 1978

    Google Scholar 

  24. Warren GB, Honslay MD, Metcalf JC, Birdsall NJM: Cholesterol is excluded from the phospholipid annulus surrounding an active calcium transport protein. Nature 255: 684–687, 1975

    Google Scholar 

  25. Caroni P, Zurini M, Clark A, Carafoli E: Further characterization and reconstitution of the purified Ca2+ -pumping ATPase of heart sarcolemma. J Biol Chem 258: 7305–7310, 1983

    Google Scholar 

  26. Zhao D, Dhalla NS: Purification and composition of Ca2+/Mg2+ ATPase from rat heart plasma membrane. Mol Cell Biochem 107: 135–149, 1991

    Google Scholar 

  27. Panagia V, Okumura K, Makino N, Dhalla NS: Stimulation of Ca2+ pump in rat heart sarcolemma by phosphatidylethanolamine N-methylation. Biochim Biophys Acta 856: 383–387, 1986

    Google Scholar 

  28. Ganguly PK, Panagia V, Okumura K, Dhalla NS: Activation of Ca2+-stimulated ATPase by phospholipid N-methylation in cardiac sarcoplasmic reticulum. Biochem Biophys Res Commun 130: 472–478, 1985

    Google Scholar 

  29. Panagia V, Makino N, Ganguly PK, Dhalla NS: Inhibition of Na+-Ca2+ exchange in heart sarcolemmal vesicles by phosphatidylethanolamine N-methylation. Ent J Biochem 166: 597–603, 1987

    Google Scholar 

  30. Panagia V, Heyliger CE, Choy PC, Dhalla NS: Solubilization of rat heart sarcolemmal 5′-nucleotidase by phosphatidylinositol specific phospholipase C. Biochim Biophys Acta 640: 802–806, 1981

    Google Scholar 

  31. Chein KR, Han A, Sen A, Buja LM, Willerson JT: Accumulation of unesterified arachidonic acid in ischemic canine myocardium. Circ Res 48: 313–322, 1981

    Google Scholar 

  32. Corr PB, Gross RW, Sobel BE: Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ Res 55: 135–154, 1984

    Google Scholar 

  33. Katz AM, Messineo FC: Lipid membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ Res 48: 1–16, 1981

    Google Scholar 

  34. Van der Vusse GJ, Prinen FW, Reneman RS: Uptake and tissue content of fatty acids in dog myocardium under normoxic and ischemic conditions. Circ Res 50: 538–546, 1982

    Google Scholar 

  35. Van Bilsen M, Van der Vusse GJ, Willemsen PHM, Coumans WA, Reneman RS: Fatty acid accumulation during ischemic reperfusion: Effects of pyruvate and POCA, a carnitine palmitoyltransferase I inhibitor. J Mol Cell Cardiol 23: 1437–1447, 1991

    Google Scholar 

  36. Lopaschuk GD, Wall SR, Olley PM, Davies NJ: Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine. Circ Res 63: 1036–1043, 1988

    Google Scholar 

  37. Paulson DJ, Noonan JJ, Ward KM, Stanley H, Sherratt A, Shug AL: Effects of POCA on metabolism and function in the ischemic rat heart. Basic Res Cardiol 81: 180–187, 1986

    Google Scholar 

  38. Molaparast-Saless F, Liedtke AJ, Nellis SH: Effects of fatty acid blocking agents, oxfenicine and 4-bromocrotonic acid on performance in aerobic and ischemic myocardium. J Mol Cell Cardiol 19: 509–520, 1987

    Google Scholar 

  39. Hekimian G, Feuvray D: Reduction of ischemia-induced acylcarnitine accumulation by TDGA and its influence on lactate dehydrogenease release in diabetic rat hearts. Diabetes 35: 906–910, 1985

    Google Scholar 

  40. Rupp H, Elimban V, Dhalla NS: Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferanse I inhibitor. FASEB J 6: 2349–2353, 1992

    Google Scholar 

  41. Denton RM, Randle PJ: Concentrations of glycerides and phospholipids in rat heart and gastronemius muscles. Biochem J 104: 423–434, 1967

    Google Scholar 

  42. Randle PJ, Garland PB, Hales CN, Newshoom EA, Denton RM, Pagson CI: Interactions of metabolism and the physiological role of insulin. Recent Prog Horm Res 22: 1–44, 1966

    Google Scholar 

  43. Lopaschuk GD, Tahiliani RVSV, -Vadlamidi S, Katz S, McNeill JH: Cardiac sarcoplasmic reticulum function in insulin or carnitine treated rats. Am J Physiol 245: H969-H976, 1983

    Google Scholar 

  44. Pieper GM, Murray WJ, Salhany JM, Wu ST, Eliot RS: Salient effects of L-carnitine on adenine-nucleotide loss and coenzyme A acylation in the diabetic heart perfused with excess palmitic acid. A phosphorus-31 NMR and chemical extract study. Biochim Biophys Acta 804: 229–240, 1984

    Google Scholar 

  45. Rodrigues B, Goyal RK, McNeill JH: Effects of hydralazine on STZ-induced diabetic rats: Prevention of hyperlipidemia and improvement in cardiac function. J Pharmacol Exp Ther 237: 292–299, 1986

    Google Scholar 

  46. Tahiliani AG, McNeill JH: Prevention of diabetes-induced myocardial dysfunction in rats by methyl palmoxirate and triiodothyronine treatment. Can J Physiol Pharmacol 63: 925–931, 1985

    Google Scholar 

  47. Xiang H, Heyliger CE, McNeill JH: Effect of myoinositol and T3 on myocardial lipids and cardiac function in streptozotocin-induced diabetic rats. Diabetes 376: 1542–1548, 1988

    Google Scholar 

  48. Nicholl TA, Lopaschuk GD, McNeill JH: Effects of free fatty acids and dichloracetate on isolated working diabetic rat heart. Am J Physiol 261: H10531–11059, 1991

    Google Scholar 

  49. Vary TC, Neely JR: A mechanism for reduced myocardial carnitine levels in diabetic animals. Am J Physiol 243: H154-H158, 1982

    Google Scholar 

  50. Rodrigues B, Xiang H, McNeill JH: Effect of L-carnitine treatment on lipid metabolism and cardiac performance in chronically diabetic rats. Diabetes 37: 1358–1364, 1988

    Google Scholar 

  51. Ferrari R, Shah KR, Hata T, Beamish RE, Dhalla NS: Subcellular defects in diabetic myocardium: Influence of propionyl L-carnitine on Ca2+ transport. In: M Nagano and NS Dhalla (eds.) The Diabetic Heart. Raven Press, New York, 1991, pp 167–181

    Google Scholar 

  52. Dhalla NS, Dixon IMC, Shah KR, Ferrari R: Beneficial effects of L-carnitine and derivatives on heart membranes in experimental diabetes. In: R. Ferrari, S Dimauro and G Sherwood (eds.) L-Carnitine and its Role in Medicine: From Function to Therapy. Academic Press, London, 1992, pp 411–426

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiovascular Sciences St. Boniface General Hospital Research Centre and Department of Physiology, Faculty of Medicine, University of Manitoba, R2H 2A6, Winnipeg, Manitoba, Canada

    Naranjan S. Dhalla, Vijayan Elimban & Heinz Rupp

Authors
  1. Naranjan S. Dhalla
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vijayan Elimban
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Heinz Rupp
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dhalla, N.S., Elimban, V. & Rupp, H. Paradoxical role of lipid metabolism in heart function and dysfunction. Mol Cell Biochem 116, 3–9 (1992). https://doi.org/10.1007/BF01270562

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01270562

Key words

Search

Navigation